Zeto seeks applicants for sponsored EEG clinical trials

NEWS RELEASE: Zeto Exhibits at Neuroscience 2023 and Will Sponsor EEG Clinical Trials

Zeto’s EEG headset [Photo courtesy of Zeto]

SANTA CLARA, Calif. — Zeto, Inc., an innovative EEG brain monitoring company, is excited to make two significant announcements as the company continues to expand the boundaries of brain monitoring.

Zeto is proud to announce its inaugural participation at the Neuroscience 2023 conference hosted by the Society for Neuroscience. Taking place from November 11-15, 2023, at the Walter E. Washington Convention Center in Washington, D.C., this event will bring together over 30,000 scientists, researchers, and clinicians making it the largest conference in neuroscience.

“At Zeto, we’ve consistently delivered substantial value to our clinical partners in hospitals and private practices. Now, we’re excited to bring the convenience of Zeto EEG to the forefront of your cl…

Read more
  • 0

How EEG and machine learning are transforming epilepsy clinical trials

[Image courtesy of peterschreiber.media/Adobe Stock]

Epilepsy is a brain disorder that triggers recurring seizures. It is the fourth the most common neurological disorders in the world, according to the Epilepsy Foundation. The Centers for Disease Control and Prevention estimates that 65 million people worldwide have active epilepsy. In 2015, 1.2% of the total U.S. population — 3 million adults and nearly 500,000 children — had active epilepsy.

There are many different causes of epilepsy, including genetics, head trauma, brain abnormalities, infection, prenatal injury and developmental disorders, such as autism.

Seizure symptoms vary greatly and can manifest in a person as uncontrollable limb movements, staring, muscle stiffness, confusion and loss of consciousness or awareness.

These symptoms are not mutually exclusive. Some patients with epilepsy experience multiple types of seizures.


Read more
  • 0